These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2512464)

  • 1. Pseudomonas aeruginosa exotoxin A primes human monocyte oxidative burst response in vitro.
    Patzer J; Nielsen H; Kharazmi A
    Microb Pathog; 1989 Aug; 7(2):147-52. PubMed ID: 2512464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation of recombinant atoxic form of exotoxin A from Pseudomonas aeruginosa.
    Kaloshin AA; Isakov MA; Mikhailova NA; Vertiev JV
    Bull Exp Biol Med; 2013 Jan; 154(3):346-50. PubMed ID: 23484197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pseudomonas aeruginosa exotoxin A antibodies in rapidly deteriorating chronic leg ulcers.
    Danielsen L; Westh H; Balselv E; Rosdahl VT; Döring G
    Lancet; 1996 Jan; 347(8996):265. PubMed ID: 8551911
    [No Abstract]   [Full Text] [Related]  

  • 4. A Pseudomonas aeruginosa alginate-exotoxin A conjugate that elicits anti-alginate and exotoxin A-neutralizing antibodies.
    Coin D; Vacheron MJ; Guinand M; Michel G
    FEMS Microbiol Immunol; 1991 Aug; 3(4):185-92. PubMed ID: 1931130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is Pseudomonas aeruginosa exotoxin A a good carrier protein for conjugate vaccines?
    Pier GB
    Hum Vaccin; 2007; 3(2):39-40; author reply 41. PubMed ID: 17268204
    [No Abstract]   [Full Text] [Related]  

  • 6. Isolation and characterizations of a novel recombinant scFv antibody against exotoxin A of Pseudomonas aeruginosa.
    Shadman Z; Farajnia S; Pazhang M; Tohidkia M; Rahbarnia L; Najavand S; Toraby S
    BMC Infect Dis; 2021 Mar; 21(1):300. PubMed ID: 33761869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Pseudomonas aeruginosa exotoxin A on IFN-gamma synthesis: expression of costimulatory molecules on monocytes and activity of NK cells.
    Michałkiewicz J; Stachowski J; Barth C; Patzer J; Dzierzanowska D; Madaliński K
    Immunol Lett; 1999 Sep; 69(3):359-66. PubMed ID: 10528802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Protective properties of anatoxin obtained from a homogeneous preparation of Pseudomonas aeruginosa exotoxin A].
    Brodinova NS; Vovk VA; Aleksandrov AD; Moroz AF
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Jun; (6):3-8. PubMed ID: 2508376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study of protective properties of recombinant atoxic form of exotoxin A and recombinant outer membrane protein F of Pseudomonas aeruginosa].
    Mikhaĭlova NA; Vertiev IuV; Kaloshin AA; Isakov MA
    Zh Mikrobiol Epidemiol Immunobiol; 2010; (2):39-44. PubMed ID: 20464999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteration of murine immune response by Pseudomonas aeruginosa exotoxin A.
    Holt PS; Misfeldt ML
    Infect Immun; 1984 Jul; 45(1):227-33. PubMed ID: 6429047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production and characterization of human monoclonal antibody recognizing the N-terminal residues of Pseudomonas aeruginosa exotoxin A.
    Ohtsuka H; Horigome K; Ochi H; Nishimoto T; Kozuki T; Kato M; Okuda T; Noguchi H
    Hybridoma; 1991 Apr; 10(2):297-307. PubMed ID: 1651902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative immunochemistry of two fragments from domains Ib and III of Pseudomonas aeruginosa exotoxin A.
    Rutault K; Vacheron MJ; Guinand M; Michel G
    Infect Immun; 1993 Dec; 61(12):5417-20. PubMed ID: 8225617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of pseudomonas exotoxin A on cytokine production in whole blood exposed to Pseudomonas aeruginosa.
    Schultz MJ; Speelman P; Zaat SA; Hack CE; van Deventer SJ; van der Poll T
    FEMS Immunol Med Microbiol; 2000 Nov; 29(3):227-32. PubMed ID: 11064270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reaction of antibody in sera from cystic fibrosis patients with non-toxic forms of Pseudomonas aeruginosa exotoxin A.
    Klinger KW; Shuster CW; Klinger J
    Eur J Clin Microbiol; 1985 Apr; 4(2):201-6. PubMed ID: 3924609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Production and properties evaluation of monoclonal antibodies against Pseudomonas aeruginosa exotoxin A].
    Soldatenkova AV; Iakovleva IV; Gavrilova NV; Mikhaĭlova NA; Sviridova VV
    Zh Mikrobiol Epidemiol Immunobiol; 2014; (1):30-5. PubMed ID: 24738291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Protective polysaccharide-protein artificial antigens from O-specific polysaccharides of Pseudomonas aeruginosa and its exotoxin A].
    Dmitriev BA; Kul'shin VA; Antsiferova NG; Vovk VA; Moroz AF
    Dokl Akad Nauk SSSR; 1988; 298(5):1277-80. PubMed ID: 2454182
    [No Abstract]   [Full Text] [Related]  

  • 17. Cloning, expression and characterization of recombinant exotoxin A-flagellin fusion protein as a new vaccine candidate against Pseudomonas aeruginosa infections.
    Tanomand A; Farajnia S; Najar Peerayeh S; Majidi J
    Iran Biomed J; 2013; 17(1):1-7. PubMed ID: 23279828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective activity of anti-exotoxin A monoclonal antibody against mice infected with toxin-producing Pseudomonas aeruginosa.
    Kohzuki T; Eguchi Y; Kato M; Irie K; Ohtsuka H; Higuchi A; Noguchi H
    J Infect Dis; 1993 Jan; 167(1):119-25. PubMed ID: 8418158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunobiological properties of recombinant atoxic forms of the Pseudomonas aeruginosa exotoxin A].
    Isakov MA; Soldatenkova AS; Kaloshin AA; Mikhaĭlova NA
    Zh Mikrobiol Epidemiol Immunobiol; 2011; (2):37-42. PubMed ID: 21598613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lucigenin- and luminol-enhanced chemiluminescence in turkey monocytes.
    Van Nerom A; Desmidt M; Ducatelle R; Haesebrouck F
    J Biolumin Chemilumin; 1997; 12(4):207-14. PubMed ID: 9481608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.